Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas. - Linden,O.; Tennvall,J.; Cavallin-Stahl,E.; Darte,L.; Garkavij,M.; Lindner,K.J.; Ljungberg,M.; Ohlsson,T.; Sjogreen,K.; Wingardh,K.; Strand,S.E. (Clin Cancer Res, 1999)